209 related articles for article (PubMed ID: 33603167)
21. Combining TP53 mutation and isoform has the potential to improve clinical practice.
Ray Das S; Delahunt B; Lasham A; Li K; Wright D; Print C; Slatter T; Braithwaite A; Mehta S
Pathology; 2024 Jun; 56(4):473-483. PubMed ID: 38594116
[TBL] [Abstract][Full Text] [Related]
22. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
23. Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis.
Haraoka Y; Akieda Y; Nagai Y; Mogi C; Ishitani T
Nat Commun; 2022 Mar; 13(1):1417. PubMed ID: 35304872
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
25. A porcine model of osteosarcoma.
Saalfrank A; Janssen KP; Ravon M; Flisikowski K; Eser S; Steiger K; Flisikowska T; Müller-Fliedner P; Schulze É; Brönner C; Gnann A; Kappe E; Böhm B; Schade B; Certa U; Saur D; Esposito I; Kind A; Schnieke A
Oncogenesis; 2016 Mar; 5(3):e210. PubMed ID: 26974205
[TBL] [Abstract][Full Text] [Related]
26. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.
Candi E; Agostini M; Melino G; Bernassola F
Hum Mutat; 2014 Jun; 35(6):702-14. PubMed ID: 24488880
[TBL] [Abstract][Full Text] [Related]
27. Regulating p73 isoforms in human tumours.
Coates PJ
J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53: it's not all one and the same.
Kennedy MC; Lowe SW
Cell Death Differ; 2022 May; 29(5):983-987. PubMed ID: 35361963
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.
Sikorska A; Flisikowska T; Stachowiak M; Kind A; Schnieke A; Flisikowski K; Switonski M
J Appl Genet; 2018 Nov; 59(4):485-491. PubMed ID: 30145695
[TBL] [Abstract][Full Text] [Related]
30. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
31. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
[TBL] [Abstract][Full Text] [Related]
32. Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity.
Bardot B; Bouarich-Bourimi R; Leemput J; Lejour V; Hamon A; Plancke L; Jochemsen AG; Simeonova I; Fang M; Toledo F
Oncogene; 2015 May; 34(22):2943-8. PubMed ID: 25088193
[TBL] [Abstract][Full Text] [Related]
33. Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.
Zheng T; Wang J; Zhao Y; Zhang C; Lin M; Wang X; Yu H; Liu L; Feng Z; Hu W
Nat Commun; 2013; 4():2996. PubMed ID: 24356649
[TBL] [Abstract][Full Text] [Related]
34. Splicing factor DHX15 affects tp53 and mdm2 expression via alternate splicing and promoter usage.
McElderry J; Carrington B; Bishop K; Kim E; Pei W; Chen Z; Ramanagoudr-Bhojappa R; Prakash A; Burgess SM; Liu PP; Sood R
Hum Mol Genet; 2019 Dec; 28(24):4173-4185. PubMed ID: 31691804
[TBL] [Abstract][Full Text] [Related]
35. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
36. p53 isoforms can regulate p53 transcriptional activity.
Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
[TBL] [Abstract][Full Text] [Related]
37. PIN3 duplication may be partially responsible for TP53 haploinsufficiency.
Winiecka-Klimek M; Szybka M; Rieske P; Piaskowski S; Bienkowski M; Walczak M; Pacholczyk M; Rostkowski M; Zieba J; Banaszczyk M; Hulas-Bigoszewska K; Peciak J; Pawliczak R; Stoczynska-Fidelus E
BMC Cancer; 2014 Sep; 14():669. PubMed ID: 25223755
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
40. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
Dando I; Cordani M; Donadelli M
IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
